Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly - Wikidata - wikimedia - TriplyDB

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

http://www.wikidata.org/entity/Q28069603

about

Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report.Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.Pituitary-Directed Therapies for Cushing's Disease.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

P2860

Q47799841-2DFD91E0-71AE-4628-B72E-5726333DDFC5 Q54144943-1E1AEC02-D48A-4D93-8C94-61F82A387117 Q54961209-D971FF8E-692F-475B-AE54-23C61A3ACB10 Q57144951-E18A2B76-4CCC-4BC5-83CB-8203377E8C12

P2860

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

http://www.wikidata.org/entity/Q28069603

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@ast

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@en

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@nl

type

label

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@ast

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@en

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@nl

prefLabel

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@ast

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@en

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@nl

P1433

Q28069603-F831C4C8-EE0A-4FC1-B7D8-B4CE89849064

P1476

Q28069603-1BE8535D-8DB5-4B9E-9C28-08519EDBC249

P2093

Q28069603-5396029E-D4E5-4EB6-8505-1BB6BA3A0CE1

P275

Q28069603-BD75C72F-1A26-4F06-ACF1-C7CA26B445C1

P2860

Q28069603-02697FF7-55A4-4866-8450-66003ACD0933

Q28069603-17755F9A-07A0-4C49-B384-97CD5A007117

Q28069603-17F35F12-F1E0-481A-9DE0-B1F67B5FBB42

Q28069603-29834F11-0C6E-4209-9F87-170C47A19B20

Q28069603-2E155325-C8E5-4654-95C5-988F2AAEE4CE

Q28069603-328C28CF-55C7-4A02-9367-311B25ED5DF6

Q28069603-40107D2E-3CF2-4FE7-9D56-6E2BFCC9DAFF

Q28069603-53E7EB98-7A39-4F3F-8A65-0D2AC508D469

Q28069603-6EE39643-2771-4E1D-A32E-6C4E96051BD1

Q28069603-7446C224-D84C-4D18-A6E0-346823D17D4A

P2888

Q28069603-2E9B20DA-DB0E-4E2D-BFDE-14A7C8E25657

P304

Q28069603-CCF52AB7-9D6E-4676-84CF-D3871FB4D204

P31

Q28069603-8B921C8A-BB58-48B9-AA21-963677B9B610

P3181

Q28069603-EB19C0B0-F9B2-47FD-ACBB-BABAB21C9565

P356

Q28069603-DD03AD62-F646-406B-A3A1-1103B70E9519

P407

Q28069603-389FDDA7-DE5F-4231-B8E2-402E696CF3A0

P433

Q28069603-27CDAEA6-3F2A-4081-BB4D-6FD3C7A8AD29

P478

Q28069603-53A8821F-9885-42B0-85B1-1B6E6E651456

P50

Q28069603-310DA209-B111-427B-B452-4F031B4A9ED2

P5008

Q28069603-2A6B9EDB-A94F-457C-8487-E4E495C59EFE

P577

Q28069603-0A671CC3-342A-48EA-8A41-5BE0D635DEC2

P698

Q28069603-96078A8D-9895-48E7-98D9-57DDE0A99715

P921

Q28069603-1EDE973F-6027-44C9-B27F-98D7A5978769

Q28069603-2DEB3217-BDF9-4C56-A1F7-41CCB6E9043F

Q28069603-3CB14133-35F1-44C2-BAA4-53C453184904

Q28069603-58CF28B0-C68C-4849-B04C-EABD55FB53C6

Q28069603-87557698-A1A1-4B26-901E-0F106534CF38

Q28069603-953C449A-17CC-4B52-BCBF-7D1BFB365769

P932

Q28069603-424C59DA-F9A5-4C62-A9CA-2FA942D1F6E0

P3181

P356

S11102-016-0734-1

P1433

P1476

Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly

@en

P2093

Julie M. Silverstein

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis

Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.

Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study.

The pathophysiological consequences of somatostatin receptor internalization and resistance.

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial

Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations.

Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.

P2888

s11102-016-0734-1

P304

536-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4583257

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11102-016-0734-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Julie M Silverstein

P5008

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27405306

http://www.w3.org/2001/XMLSchema#string

P921

pituitary-dependent Cushing's disease

nerve tissue proteins

P932

4996868

http://www.w3.org/2001/XMLSchema#string